Lv3
400 积分 2024-05-13 加入
The SGLT2 inhibitor dapagliflozin improves kidney function in glycogen storage disease XI
2天前
已完结
Crosstalk Between Lipids and Mitochondria in Diabetic Kidney Disease
5个月前
已完结
Oxidative Stress Induced by Lipotoxicity and Renal Hypoxia in Diabetic Kidney Disease and Possible Therapeutic Interventions: Targeting the Lipid Metabolism and Hypoxia
5个月前
已完结
Interplay of lipid metabolism and inflammation in podocyte injury
5个月前
已完结
Lipid-modifying therapy in chronic kidney disease: Pathophysiological and clinical considerations
5个月前
已完结
The role of renal hypoxia in the pathogenesis of diabetic kidney disease: a promising target for newer renoprotective agents including SGLT2 inhibitors?
5个月前
已完结
The key role of altered tubule cell lipid metabolism in kidney disease development
5个月前
已完结
Elevation of JAML Promotes Diabetic Kidney Disease by Modulating Podocyte Lipid Metabolism
5个月前
已完结
Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis
5个月前
已完结
The immunology of atherosclerosis
5个月前
已完结
皖公网安备34019202002308
